SCHEMBL18020186

SCHEMBL18020186

O=c1[nH]c(=O)n(-c2ccc3c(c2)c2ccccc2n3-c2ccccc2)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 6/20 0.54
L3MBTL1 Q9Y468 2/20 0.51
KDM4E B2RXH2 2/20 0.51
ATM Q13315 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
KDR P35968 1/20 0.39
NTRK1 P04629 3/20 0.39
NTRK2 Q16620 3/20 0.39
IGF1R P08069 2/20 0.39
FGFR1 P11362 2/20 0.39
NTRK3 Q16288 2/20 0.39
GAA P10253 2/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18919887 0.89 L3MBTL1 (0.57) MAT2AL3MBTL1KDM4EATMMEN1
SCHEMBL9836581 0.88 MAT2A (0.61) MAT2AL3MBTL1KDM4EATMMEN1
SCHEMBL16605620 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL3334280 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL21671314 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL25010820 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL30288 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL24531917 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL16573903 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL30777262 0.83 L3MBTL1 (0.75) L3MBTL1KDM4EATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257093-B1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2021-07-07 EP disclosed
US-10249831-B2 Electronic device containing cyclic lactams MERCK PATENT GMBH (DE) 2019-04-02 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
WO-2016128103-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2016-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10249831-B2 Electronic device containing cyclic lactams OXA1L, UROD, MRPL21 MAT2A 4059/4885L3MBTL1 3138/4885KDM4E 2116/4885
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS OXA1L, UROD, MRPL21 MAT2A 4059/4885L3MBTL1 3138/4885KDM4E 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.